CS207455B2 - Method of preparation of the new therapeutic mixture - Google Patents
Method of preparation of the new therapeutic mixture Download PDFInfo
- Publication number
- CS207455B2 CS207455B2 CS773204A CS320477A CS207455B2 CS 207455 B2 CS207455 B2 CS 207455B2 CS 773204 A CS773204 A CS 773204A CS 320477 A CS320477 A CS 320477A CS 207455 B2 CS207455 B2 CS 207455B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- compounds
- polyvinylpyrrolidone
- hydroxy
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762621906 DE2621906A1 (de) | 1976-05-17 | 1976-05-17 | Neue therapeutische mischung und verfahren zu deren herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS207455B2 true CS207455B2 (en) | 1981-07-31 |
Family
ID=5978199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS773204A CS207455B2 (en) | 1976-05-17 | 1977-05-16 | Method of preparation of the new therapeutic mixture |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS52139730A (xx) |
| AT (1) | AT366574B (xx) |
| AU (1) | AU513718B2 (xx) |
| BE (1) | BE854694A (xx) |
| CA (1) | CA1088865A (xx) |
| CS (1) | CS207455B2 (xx) |
| DE (1) | DE2621906A1 (xx) |
| ES (1) | ES458819A1 (xx) |
| FR (1) | FR2351657A1 (xx) |
| GB (1) | GB1565447A (xx) |
| GR (1) | GR72995B (xx) |
| HK (1) | HK3283A (xx) |
| HU (1) | HU175167B (xx) |
| IE (1) | IE45197B1 (xx) |
| IL (1) | IL52101A (xx) |
| MY (1) | MY8400062A (xx) |
| NL (1) | NL177981C (xx) |
| NZ (1) | NZ184111A (xx) |
| PH (1) | PH20257A (xx) |
| PT (1) | PT66552B (xx) |
| SE (1) | SE425545B (xx) |
| ZA (1) | ZA772935B (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2935515A1 (de) * | 1979-09-03 | 1981-03-19 | Fa. Dr. Willmar Schwabe, 7500 Karlsruhe | Arzneipraeparat |
| JPH0227013U (xx) * | 1988-08-10 | 1990-02-22 | ||
| IL145550A0 (en) | 1999-03-26 | 2002-06-30 | Pozen Inc | High potency dihydroergotamine compositions |
-
1976
- 1976-05-17 DE DE19762621906 patent/DE2621906A1/de active Granted
-
1977
- 1977-05-09 SE SE7705340A patent/SE425545B/xx not_active IP Right Cessation
- 1977-05-12 FR FR7714507A patent/FR2351657A1/fr active Granted
- 1977-05-13 GB GB20210/77A patent/GB1565447A/en not_active Expired
- 1977-05-13 PH PH19768A patent/PH20257A/en unknown
- 1977-05-13 NL NLAANVRAGE7705306,A patent/NL177981C/xx not_active IP Right Cessation
- 1977-05-16 ES ES458819A patent/ES458819A1/es not_active Expired
- 1977-05-16 CA CA278,488A patent/CA1088865A/en not_active Expired
- 1977-05-16 IE IE1001/77A patent/IE45197B1/en unknown
- 1977-05-16 CS CS773204A patent/CS207455B2/cs unknown
- 1977-05-16 BE BE177623A patent/BE854694A/xx not_active IP Right Cessation
- 1977-05-16 AT AT0347677A patent/AT366574B/de not_active IP Right Cessation
- 1977-05-16 NZ NZ184111A patent/NZ184111A/xx unknown
- 1977-05-16 HU HU77SA3035A patent/HU175167B/hu not_active IP Right Cessation
- 1977-05-16 PT PT66552A patent/PT66552B/pt unknown
- 1977-05-16 JP JP5624877A patent/JPS52139730A/ja active Granted
- 1977-05-16 IL IL52101A patent/IL52101A/xx unknown
- 1977-05-16 AU AU25169/77A patent/AU513718B2/en not_active Expired
- 1977-05-17 GR GR53485A patent/GR72995B/el unknown
- 1977-05-17 ZA ZA00772935A patent/ZA772935B/xx unknown
-
1983
- 1983-01-20 HK HK32/83A patent/HK3283A/xx unknown
-
1984
- 1984-12-30 MY MY62/84A patent/MY8400062A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1565447A (en) | 1980-04-23 |
| NZ184111A (en) | 1980-02-21 |
| JPS52139730A (en) | 1977-11-21 |
| IL52101A (en) | 1980-01-31 |
| ZA772935B (en) | 1979-01-31 |
| FR2351657A1 (fr) | 1977-12-16 |
| PT66552B (en) | 1979-09-03 |
| MY8400062A (en) | 1984-12-31 |
| IE45197B1 (en) | 1982-07-14 |
| SE7705340L (sv) | 1977-11-18 |
| CA1088865A (en) | 1980-11-04 |
| NL177981C (nl) | 1986-01-02 |
| IE45197L (en) | 1977-11-17 |
| JPS628413B2 (xx) | 1987-02-23 |
| AU513718B2 (en) | 1980-12-18 |
| SE425545B (sv) | 1982-10-11 |
| HK3283A (en) | 1983-01-20 |
| DE2621906A1 (de) | 1977-12-01 |
| ES458819A1 (es) | 1978-08-01 |
| GR72995B (xx) | 1984-01-24 |
| NL177981B (nl) | 1985-08-01 |
| PH20257A (en) | 1986-11-14 |
| PT66552A (en) | 1977-06-01 |
| IL52101A0 (en) | 1977-07-31 |
| AT366574B (de) | 1982-04-26 |
| NL7705306A (nl) | 1977-11-21 |
| DE2621906C2 (xx) | 1988-04-21 |
| BE854694A (fr) | 1977-11-16 |
| ATA347677A (de) | 1981-09-15 |
| FR2351657B1 (xx) | 1980-01-18 |
| HU175167B (hu) | 1980-05-28 |
| AU2516977A (en) | 1978-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL217835B1 (pl) | Preparat farmaceutyczny zawierający sól wapniową atorwastatyny, sposób wytwarzania tego preparatu i jego zastosowanie do leczenia hipercholesterolemii i hiperlipidemii | |
| SK286562B6 (sk) | Kryštalická forma A omeprazolu, kompozícia a farmaceutický prípravok s jej obsahom, spôsob jej prípravy a jej použitie | |
| US4226861A (en) | N-Lower-alkyl 3-phenoxy-1-azetidinecarboxamides | |
| JPH0825879B2 (ja) | 抗うつまたは抗パーキンソン病薬 | |
| PL197545B1 (pl) | Sposób wytwarzania preparatu farmaceutycznego, zawierającego jako substancję czynną tolperyzon lub jego sól, do podawania doustnego, o przedłużonym uwalnianiu substancji czynnej | |
| CS208661B2 (en) | Method of making the n-/2-phenyl-2-hydroxyethyl/-1,1-dimethyl-3-phenylpropylamin derivatives | |
| CZ20002392A3 (cs) | Léčivo pro léčbu obezity a farmaceutický prostředek k tomuto účelu | |
| CA2321369C (en) | Dosing regimens for lasofoxifene | |
| SK281193B6 (sk) | Tableta so zlepšenou biodostupnosťou účinnej látky, kyseliny klodrónovej, spôsob jej výroby a použitie mikrokryštalickej celulózy | |
| US7955620B2 (en) | Stable oral composition | |
| KR20140111044A (ko) | 구연산아일데나필 결정 형태 o 및 그의 제조방법과 용도 | |
| CS207455B2 (en) | Method of preparation of the new therapeutic mixture | |
| US6482417B2 (en) | Stable pharmaceutical formulation comprising torsemide modification II | |
| JP2002532429A (ja) | 薬学的処方物 | |
| CZ287563B6 (en) | Pharmaceutical preparations for treating hyperglycemia | |
| EP1880992A1 (en) | Stable modifications of tegaserod hydrogen maleate | |
| MXPA02000033A (es) | Polimorfos de un diclorhidrato cristalino de azobiciclo (2, 2, 2)oct-3-ilamina y sus composiciones farmaceuticas. | |
| KR100476606B1 (ko) | 결정질 아자비시클로(2,2,2)옥탄-3-아민 시트레이트의다형체 및 그의 제약 조성물 | |
| US20050069584A1 (en) | Diphenhydramine tannate solid dose compositions and methods of use | |
| US3155584A (en) | Compositions and method of inhibiting monoamine oxidase and treating hypertension | |
| CS246078B2 (en) | Method of production of pyroxycame salts with base deposited on pharmaceutically accepted carrier | |
| US3993778A (en) | Anti-ulcerogenic pharmaceutical compositions containing a 2-amino-3,5-dibromo-benzylamine and method of use | |
| HU192050B (en) | Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist | |
| US6784315B2 (en) | Stilbene derivative crystal and method for producing the same | |
| SK11695A3 (en) | Use of 3-benzoyl-3,7-diazobicyclo£3,3,1| nonane compounds as antiarhytmic effective medicament and method of its production |